Fennec Pharmaceuticals (NASDAQ:FENC – Free Report) had its price objective trimmed by HC Wainwright from $18.00 to $17.00 in a research report report published on Friday, Marketbeat Ratings reports. The brokerage currently has a buy rating on the stock. Separately, Cantor Fitzgerald raised their price target on Fennec Pharmaceuticals from $12.00 to $16.00 and gave […]